Cell Reports. Medicine
Overview
Cell Reports. Medicine is a scientific journal, published by Cell Press since 2020 in English. The journal's country of origin is United States and its primary focus areas are general medicine and biology.
Details
Details
Abbr.
Cell Rep Med
Publisher
Cell Press
Start
2020
End
Continuing
e-ISSN
2666-3791
Country
United States
Language
English
Specialties
General Medicine
Biology
Biology
Metrics
Metrics
h-index / Ranks: 7336
50
SJR / Ranks: 344
4276
CiteScore / Ranks: 838
12.70
Recent Articles
1.
Zhang J, Tabima D, Vereide D, Zeng W, Albano N, Lyon S, et al.
Cell Rep Med
. 2025 Mar;
:102002.
PMID: 40068684
Autologous vascular grafts, the only clinically approved option for small-diameter (<6 mm) revascularizations, require invasive harvesting and have limited availability and variable quality. To address these challenges, we develop a...
2.
Yan S, Zhang W, Li X, Dutta S, Castle A, Liu Y, et al.
Cell Rep Med
. 2025 Mar;
:101999.
PMID: 40056910
Accurate diagnosis of early Parkinson's disease requires platforms suitable for detecting minute amounts of neuronally derived biomarkers in the massive protein excess of easily accessible biofluids such as blood. Here,...
3.
Kowala A, Boot J, Meng J, Mein C, Pourquie O, Connelly J, et al.
Cell Rep Med
. 2025 Mar;
:102019.
PMID: 40056909
Transplantation of human myogenic progenitor cells (MPCs) is a promising therapeutic strategy for treating muscle-wasting diseases, e.g., Duchenne muscular dystrophy (DMD). To increase engraftment efficiency of donor stem cells, modulation...
4.
Mayer C, Walch O, Dempsey W, Hannay K, Clingan C, Bowen Z, et al.
Cell Rep Med
. 2025 Mar;
:102001.
PMID: 40056908
Lighting interventions can mitigate fatigue by promoting circadian rhythmicity. We test whether individualized, wearable-based lighting interventions delivered via a mobile app reduce cancer-related fatigue in a randomized controlled trial with...
5.
Cao Z, Meng Z, Li J, Tian Y, Lu L, Wang A, et al.
Cell Rep Med
. 2025 Mar;
:102017.
PMID: 40056907
Conventional neoadjuvant chemotherapy provides limited benefit for patients with resectable non-small cell lung cancer (NSCLC). Recently, neoadjuvant chemoimmunotherapy (NCIT) has transformed the perioperative management of NSCLC by priming systemic anti-tumor...
6.
Zhang T, Wang B, Wei Y, Gan H, Fang B, Li X, et al.
Cell Rep Med
. 2025 Mar;
:102018.
PMID: 40056906
Preclinical studies suggest synergistic effects between androgen receptor inhibitors and poly(adenosine diphosphate-ribose) polymerase (PARP) inhibitors. This phase 2 trial (NCT05223582) evaluates neoadjuvant fuzuloparib plus abiraterone in 35 treatment-naive men with...
7.
Zong P, Li C, Feng J, Yue Z, Legere N, Yu A, et al.
Cell Rep Med
. 2025 Mar;
:101998.
PMID: 40056905
Hyperlipidemia induces cellular dysfunction and is strongly linked to various diseases. The transient receptor potential channel melastatin 2 (TRPM2) plays a critical role in endothelial injury, immune cell activation, and...
8.
Yang S, Qiu X, Yang Y, Wu J, Wang S, Zheng B, et al.
Cell Rep Med
. 2025 Mar;
:102000.
PMID: 40056904
Leukotriene A4 hydrolase (LTA4H), an inflammatory mediator, has garnered attention for its role in the development of chronic lung diseases and various cancers. Our study highlights the protective role of...
9.
Johansen V, Gradel A, Holm S, Cuenco J, Merrild C, Petersen N, et al.
Cell Rep Med
. 2025 Mar;
:101996.
PMID: 40056903
Liver-expressed antimicrobial peptide 2 (LEAP2) is an endogenous antagonist and inverse agonist of the ghrelin receptor, countering ghrelin's effects on cell signaling and feeding. However, despite an emerging interest in...
10.
Lopez J, Milhem M, Butler M, Thistlethwaite F, Van Tine B, DAngelo S, et al.
Cell Rep Med
. 2025 Mar;
:101994.
PMID: 40054461
IMCnyeso, an immune mobilizing monoclonal T cell receptor against cancer (ImmTAC) bispecific (New York esophageal squamous cell carcinoma [NY-ESO]×CD3) T cell engager, targets an NY-ESO-1/L-antigen family member-1 isoform A (LAGE-1A)...